Brief: Biophytis SA Says Co And The University Of Liège Explore The Potential Of Sarconeos (Bio101) In The Treatment Of Viral Respiratory Failure
05/12/2023 11:08
Dec 5 (Reuters) - Biophytis SA ALBPS.PA :
* BIOPHYTIS SA - CO AND THE UNIVERSITY OF LIÈGE EXPLORE THE
POTENTIAL OF SARCONEOS (BIO101) IN THE TREATMENT OF VIRAL
RESPIRATORY FAILURE
Source text for Eikon: ID:
Further company coverage: ALBPS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon